Yang QC - Search Results

1

Lymphoepithelioma-like carcinoma of the submandibular salivary gland: a case report.

Sun XN, Xu J, Yang QC, Hu JB, Wang Q. Sun XN, et al. Among authors: yang qc. Chin Med J (Engl). 2006 Aug 5;119(15):1315-7. Chin Med J (Engl). 2006. PMID: 16919194 No abstract available.

2

Combined modality therapy following bladder conservation surgery for bladder cancers.

Sun X, Hu J, Yang Q. Sun X, et al. Chin Med J (Engl). 2002 Oct;115(10):1548-51. Chin Med J (Engl). 2002. PMID: 12490108

3

Pre-operative radiochemotherapy of locally advanced rectal cancer.

Sun XN, Yang QC, Hu JB. Sun XN, et al. Among authors: yang qc. World J Gastroenterol. 2003 Apr;9(4):717-20. doi: 10.3748/wjg.v9.i4.717. World J Gastroenterol. 2003. PMID: 12679918 Free PMC article. Clinical Trial.

4

Three-dimensional conformal radiotherapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer.

Hu JB, Sun XN, Yang QC, Xu J, Wang Q, He C. Hu JB, et al. Among authors: yang qc. World J Gastroenterol. 2006 Apr 28;12(16):2610-4. doi: 10.3748/wjg.v12.i16.2610. World J Gastroenterol. 2006. PMID: 16688811 Free PMC article. Clinical Trial.

5

Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma.

Sun XN, Cao WG, Wang X, Wang Q, Gu BX, Yang QC, Hu JB, Liu H, Zheng S. Sun XN, et al. Among authors: yang qc. Tumour Biol. 2011 Dec;32(6):1183-90. doi: 10.1007/s13277-011-0221-2. Epub 2011 Aug 19. Tumour Biol. 2011. PMID: 21853312

6

Concurrent Chemoradiotherapy in Curatively Resected Gallbladder Carcinoma: A Propensity Score-Matched Analysis.

Gu B, Qian L, Yu H, Hu J, Wang Q, Shan J, Shi L, Liu H, Yang Q, Liang X, Cai X, Sun X. Gu B, et al. Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):138-145. doi: 10.1016/j.ijrobp.2017.09.029. Epub 2017 Sep 20. Int J Radiat Oncol Biol Phys. 2018. PMID: 29066119

7

[Treatment of acute radiation pneumonia with Qingfei Huatan Quyu method].

Lin SY, Han XH, Yang QC. Lin SY, et al. Among authors: yang qc. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 May;28(5):414-7. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008. PMID: 18672767 Clinical Trial. Chinese.

8

Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy.

Zhang L, Zhang B, Zhang MJ, Li W, Li H, Jiao Y, Yang QC, Wang S, Liu YT, Song A, Feng HT, Sun J, Kwok RTK, Lam JWY, Tang BZ, Sun ZJ. Zhang L, et al. Among authors: yang qc. Nat Commun. 2025 Jan 2;16(1):44. doi: 10.1038/s41467-024-55430-4. Nat Commun. 2025. PMID: 39747845 Free PMC article.

9

The regulation of pyroptosis by post-translational modifications: molecular mechanisms and therapeutic targets.

Zhou YR, Dang JJ, Yang QC, Sun ZJ. Zhou YR, et al. Among authors: yang qc. EBioMedicine. 2024 Nov;109:105420. doi: 10.1016/j.ebiom.2024.105420. Epub 2024 Oct 30. EBioMedicine. 2024. PMID: 39476537 Free PMC article. Review.

10

Correction to "Engineering Multienzyme-Mimicking Covalent Organic Frameworks as Pyroptosis Inducers for Boosting Antitumor Immunity".

Zhang L, Yang QC, Wang S, Xiao Y, Wan SC, Deng H, Sun ZJ. Zhang L, et al. Among authors: yang qc. Adv Mater. 2024 Oct;36(40):e2411797. doi: 10.1002/adma.202411797. Epub 2024 Aug 29. Adv Mater. 2024. PMID: 39206594 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters